Form EFFECT Can-Fite BioPharma Ltd.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 9, 2026 5:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JC AUTOCARBON Opens Factory-Direct Carbon Fiber Parts Program to Global Tuning Shops and Distributors
- Miata Intersects 43.0 m at 2.42 g/t Au, Including 4.0 m at 17.11 g/t Au at Jons Trend and Confirms Continuity with Big Berg at Sela Creek, Suriname
- KEYCORP REPORTS THIRD QUARTER 2026 NET INCOME OF $537 MILLION, OR $0.51 PER DILUTED COMMON SHARE; DILUTED EPS INCREASED 24% YEAR-OVER-YEAR
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share